StockDrifts LogoStockDrifts

Ally Bridge Group (ny) 13F Portfolio

Portfolio Manager
Ally Bridge Group (ny) LLC
Performance
+17.94% (2026 Q2)
AUM (13F)
$113.07M
# of Holdings
23
Performance Rank
Allocation (Top 20)
90.9%
Latest filing
Q2 2026

Ally Bridge Group (ny) LLC Holdings Map

Top 22 Ally Bridge Group (ny) LLC Holdings

Top 10 holdings

StockCompany% Port.SharesValueActivityOwnershipAvg. CostDate
NERV
MINERVA NEUROSCIENCES INC
15.56%2.18M$12.1M
+31.43%(+520.30K)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 1.66M shares2026-Q1: 1.66M shares2026-Q2: 2.18M shares
$3.71(+23.53%)
2026-06-30
PMN
PROMIS NEUROSCIENCES INC
10.52%620.3K$8.2M
+49.76%(+206.10K)
2025-Q2: 53.4K shares2025-Q3: 249.3K shares2025-Q4: 249.3K shares2026-Q1: 414.2K shares2026-Q2: 620.3K shares
$14.72(+0.96%)
2026-06-30
AXSM
AXSOME THERAPEUTICS INC
5.2%16.5K$4.0Mnew2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 0 shares2026-Q1: 0 shares2026-Q2: 16.5K shares
$84.38(+153.22%)
2026-06-30
ASMB
ASSEMBLY BIOSCIENCES INC
4.96%140.0K$3.8Mnew2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 0 shares2026-Q1: 0 shares2026-Q2: 140.0K shares
$27.06(+21.77%)
2026-06-30
WHWK
WHITEHAWK THERAPEUTICS INC
4.83%817.9K$3.7M
+0.00%(+0)
2025-Q2: 817.9K shares2025-Q3: 817.9K shares2025-Q4: 817.9K shares2026-Q1: 817.9K shares2026-Q2: 817.9K shares
$2.61(+71.05%)
2026-06-30
EWTX
EDGEWISE THERAPEUTICS INC
4.36%83.3K$3.4M
-48.26%(-77.70K)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 195.0K shares2026-Q1: 161.0K shares2026-Q2: 83.3K shares
$23.53(+87.72%)
2026-06-30
CLYM
CLIMB BIO INC
4.19%249.2K$3.2Mnew2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 0 shares2026-Q1: 0 shares2026-Q2: 249.2K shares
$5.62(+190.46%)
2026-06-30
KURA
KURA ONCOLOGY INC
4.1%290.0K$3.2Mnew2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 0 shares2026-Q1: 0 shares2026-Q2: 290.0K shares
$9.35(+16.15%)
2026-06-30
CTMX
CYTOMX THERAPEUTICS INC.
3.75%775.0K$2.9M
-13.89%(-125.00K)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 0 shares2026-Q1: 900.0K shares2026-Q2: 775.0K shares
$4.48(-23.44%)
2026-06-30
AVTX
AVALO THERAPEUTICS INC
3.57%150.0K$2.8Mnew2025-Q2: 0 shares2025-Q3: 178.1K shares2025-Q4: 0 shares2026-Q1: 0 shares2026-Q2: 150.0K shares
$8.85(+121.36%)
2026-06-30

About Ally Bridge Group (ny) LLCโ€™s portfolio

Ally Bridge Group (ny) LLC reports $113.07M in US-listed equity holdings across 23 positions in its most recent 13F filing. Its largest disclosed positions are NERV (15.6%), PMN (10.5%) and AXSM (5.2%). The top 20 holdings account for 90.9% of reported assets. Its disclosed equity book has returned +271.00% on a three-year cumulative basis. Figures reflect the Q2 2026 filing.

Portfolio concentration

Portfolio concentration
NERV โ€” 16.8% ($12.08M)PMN โ€” 11.4% ($8.16M)AXSM โ€” 5.6% ($4.04M)ASMB โ€” 5.4% ($3.85M)WHWK โ€” 5.2% ($3.75M)EWTX โ€” 4.7% ($3.38M)CLYM โ€” 4.5% ($3.25M)KURA โ€” 4.4% ($3.18M)CTMX โ€” 4.0% ($2.91M)AVTX โ€” 3.9% ($2.77M)Other โ€” 34.1% ($24.52M)
66%in top 10
  • NERV16.8%
  • PMN11.4%
  • AXSM5.6%
  • ASMB5.4%
  • WHWK5.2%
  • EWTX4.7%
  • CLYM4.5%
  • KURA4.4%
  • CTMX4.0%
  • AVTX3.9%
  • Other34.1%

Portfolio changes

What the fund actually did

Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.

New buys
9
AXSMAXSOME THERAPEUTICS INC5.2%
ASMBASSEMBLY BIOSCIENCES INC5.0%
CLYMCLIMB BIO INC4.2%
KURAKURA ONCOLOGY INC4.1%
+5 opened
Added to
2
NERVMINERVA NEUROSCIENCES INC+31.4%
PMNPROMIS NEUROSCIENCES INC+49.8%
Trimmed
9
OVIDOVID THERAPEUTICS INC-77.8%
SLDBSOLID BIOSCIENCES INC-66.6%
URGNUROGEN PHARMA LTD-65.8%
EWTXEDGEWISE THERAPEUTICS INC-48.3%
+5 more

Unlock alerts, watchlists & AI chat

Sign up free to track Ally Bridge Group (ny) LLC, compare funds side by side, and get alerts the moment positions change.

Source filings

Holdings on this page are parsed from Ally Bridge Group (ny) LLCโ€™s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1822947). View Ally Bridge Group (ny) LLCโ€™s 13F filings on SEC

More 13F analyses

View all